Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. CLL is one of the malignancies that's ...

The discussion will wrap up with perspectives on the future of CLL treatment, including anticipated improvements in patient care and quality of life, emerging therapies, and evolving patient roles in ...

Chronic lymphocytic leukemia (CLL) often grows very slowly. Because this cancer can take many years to cause any symptoms or problems, you may decide to put off treatment. During this time, your ...

Chronic lymphocytic leukemia (CLL) may have a genetic basis. However, the risk of passing it down to future generations remains low. If a person has a family member with CLL, they do not usually need ...

About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during clinical ...

Do CLL Alternative Therapies Work? Targeted drugs, surgery, and radiation are common treatments for chronic lymphocytic leukemia (CLL), but complementary therapy can also play a role in helping manage ...

Chronic lymphocytic leukemia (CLL) does not always cause symptoms in the beginning. They may not appear until the condition advances. When CLL symptoms do develop, they can include swollen lymph nodes ...

Randomized trials of venetoclax plus anti-CD20 antibodies as first-line treatment in fit patients (i.e., those with a low burden of coexisting conditions) with advanced chronic lymphocytic leukemia ...